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Background: Conformational stability and folding of retinoblastoma tumor suppressor are unknown to date.
Results: The metastable RbAB domain undergoes oligomerization and aggregation, which are suppressed by natural ligands.
Conclusion: RbAB requires binding to ligands or is prone to inactivation.
Significance: Despite a different sequence and fold, Rb shares tumor suppression and multiligand binding with p53 where
marginal stability and oligomerization may lead to inactivation.
The retinoblastoma tumor suppressor (Rb) controls the
proliferation, differentiation, and survival of cells in most
eukaryoteswith a role in the fate of stem cells. Its inactivation by
mutation or oncogenic viruses is required for cellular transfor-
mation and eventually carcinogenesis. The high conservation of
the Rb cyclin fold prompted us to investigate the link between
conformational stability and ligand binding properties of the
RbAB pocket domain. RbAB unfolding presents a three-state
transition involving cooperative secondary and tertiary struc-
ture changes and a partially folded intermediate that can
oligomerize. The first transition corresponds to unfolding of the
metastable B subdomain containing the binding site for the
LXCXE motif present in cellular and viral targets, and the sec-
ond transition corresponds to the stable A subdomain. The low
thermodynamic stability of RbAB translates into a propensity to
rapidly oligomerize and aggregate at 37 °C (T50 28min) that is
suppressed by human papillomavirus E7 and E2F peptide
ligands, suggesting that Rb is likely stabilized in vivo through
binding to target proteins. We propose that marginal stability
and associated oligomerization may be conserved for function
as a “hub” protein, allowing the formation ofmultiprotein com-
plexes, which could constitute a robust mechanism to retain its
cell cycle regulatory role throughout evolution. Decreased sta-
bility and oligomerization are shared with the p53 tumor sup-
pressor, suggesting a link between folding and function in these
two essential cell regulators that are inactivated inmost cancers
and operate within multitarget signaling pathways.
The retinoblastoma tumor suppressor (Rb)5 is a central reg-
ulator of cell cycle progression, development, and differentia-
tion that modulates the activity of E2F proteins and other
transcription factors (1, 2). Rb also interacts with chromatin-
remodeling enzymes, leading to control of chromatin state and
expression of specific target genes (3), and has recently been
shown to play a role in stem cell biology (4). Despite extensive
divergence among its components, the signaling network reg-
ulating the cell cycle is conserved throughout evolution of
eukaryotes from yeasts tomammals (5). The Rb/E2F regulatory
node is strikingly conserved in organisms as divergent as uni-
cellular algae, plants, worms, and mammals, pointing to the
central role of this ancient regulatory module (6, 7). Rb is con-
sidered as a “hub” protein of the cell cycle interaction network
because of its ability to bind to and regulate the activity of mul-
tiple proteins involved in cell cycle control (8).
Rbwas the first tumor suppressor to be identified in the pedi-
atric tumor retinoblastoma and is further inactivated in glio-
blastoma;melanoma; and lung, breast, and liver cancers among
others (9). On the other hand, Rb is also targeted by several
DNA and RNA viruses such as human papillomavirus (HPV),
hepatitis C virus, and Merkel cell polyomavirus, which are
linked to the development of cervical, liver, and Merkel cell
carcinoma, respectively (10–12). Most mutations of the RB1
gene correspond to small insertions or deletions and to early
termination with a smaller proportion of missense mutations
(13, 14). Rb cooperates with p53 in tumor suppression, and loss
of function of both p53 and Rb is thought to be a virtually uni-
versal feature of tumorigenesis (15). However, the conse-
quences of Rb loss on cancer initiation and progression are only
beginning to be uncovered. Based on its inactivation in tumors,
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Rb has been recently proposed as a potential target for antican-
cer strategies, and it has been suggested that Rb levels could be
considered for guiding cancer treatments (16).
HumanRb is a 105-kDa protein composed of structuredRbN
(17) and RbAB (18) domains followed by a disordered RbC
domain that becomes ordered upon binding to E2F (19). The
RbN and RbAB domains are linked by a flexible stretch (20).
The RbAB domain, termed “small pocket” or “pocket domain,”
is the primary site formolecular interactions betweenRb and its
binding partners (21) and together with RbC forms the “large
pocket,” which is sufficient for cell cycle arrest and transcrip-
tional repression functions. The RbAB domain is also the site of
most tumorigenic missense mutations (14) and presents the
double cyclin fold topology (see Fig. 1), a highly conserved
structural motif found in a nuclear regulatory protein super-
family that includes cyclins, the basal transcription factor
TFIIB, and “pocket” family members p107, p130, and Rb, all of
which function as protein recognition modules (22, 23). The
double cyclin fold is formed by two five-helix structural cores
with additional helices in each family (18, 22). In RbAB, the A
and B cyclin folds present five and three additional helices,
respectively, and are connected by a 60-residue flexible linker
(20). Both subdomains associate through an extensive 2013-Å2
interface formed by a compact hydrophobic core (18).
The RbAB domain contains two highly conserved protein
interaction surfaces, the LXCXE and E2F clefts. Cellular factors
containing the LXCXE motif such as SWI/SNF complexes,
DNMT1, Rbp2, and HDAC1/2 mediate transcriptional repres-
sion and chromatin regulation (21, 24) by interacting with the
LXCXE cleft located in the B subdomain (18) (see Fig. 1). An Rb
knock-in allele carrying amutation that prevents binding to the
LXCXE cleft promotes tumor formation and chromosome
instability in p53-deficient mice (25), highlighting the impor-
tance of LXCXE interactions for tumor suppression. The E2F
cleft, located at the A/B interface, binds to a helical motif from
the E2F transactivation domain (E2F-TD) (18, 26) (Fig. 1), an
interaction that is essential for Rb-mediated G1 cell cycle arrest
(1). Both the LXCXE and E2F clefts are targeted by viral pro-
teins, among them the small DNA tumor virus proteins HPV
E7, adenovirus E1A, and polyomavirus T antigen, highlighting
their importance for virus-mediated control of the host cell
cycle (27).
Protein conformational stability and dynamics are closely
linked to their function and mechanisms of inactivation (28) as
low thermodynamic stabilities can cause native states to be
highly sensitive to destabilizing mutations, and aggregation-
prone forms of proteins may be involved in disease (29, 30).
Moreover, unstable or highly dynamic proteins may also be
more sensitive to proteolysis in vivo (31). Structure-function
studies have provided insights into the mechanisms of inacti-
vation of the p53 and p16INKA tumor suppressors (32, 33).
Mutation of the multifunctional p53 protein in over 50% of
human cancers leads to either loss of function or dominant
negative oncogenic gain of function phenotypes (33, 34),
whereas loss of function or overexpression of the CDK4/6
inhibitor p16INKA is also a hallmark of multiple types of cancer
(34, 35). Tumorigenic mutations in the marginally stable p53
core domain (p53CD) and in p16INK4A yield unstable proteins
that are unfolded and prone to aggregation under physiological
conditions (32, 36, 37), showing that low thermodynamic sta-
bility and its associated misfolding and aggregation are linked
to loss of function of both tumor suppressors.
Despite their central importance in gene regulatory and pro-
tein interaction networks, current knowledge of the structure-
function relationships and conformational stability of cyclin
fold proteins is very scarce (21). Although a few studies from
TFIIB and Cyclin A suggest that these proteins have low stabil-
ity and a high plasticity (38–40), recent work on Rb showed
that its inactivation by phosphorylation involves multiple con-
formational rearrangements, indicating that Rb plasticity is
required for function (17, 19, 20, 41, 42). However, the confor-
mational stability and dynamics of Rb or its domains have not
been studied to date. This type of work is fundamental for
developing effective therapeutic approaches targeting Rb and
for understanding its role as a hub in a large protein signaling
network. Biophysical studies of multidomain proteins such as
Rb are challenging because they frequently present low levels of
recombinant expression, have disordered regions, and are
prone to aggregation, making them difficult to handle in vitro.
In these cases, the domain fragmentation approach presents a
valuable starting point that provides information on the prop-
erties of individual domains, setting the basis for studies of
larger fragments or the full-length protein, as exemplified by its
success in the study of the p53 tumor suppressor (33). Although
the behavior of individual domainsmay bemodified by domain
interactions in vivo, the properties of major domains within
multidomain proteins frequently have a strong impact on the
full-length protein. For example, the stability and levels of
folded p53 in vivo are dictated by the p53CD (43, 44) with addi-
tionalmodulation by domain interactions and phosphorylation
(45, 46).
FIGURE 1. Structure of the RbABdomain and its LXCXE and E2F ligands.A
ribbon representation of the RbAB domain (Protein Data Bank code 1N4M)
indicating the relativeorientationsof theRbABAandB subdomains (darkand
light gray, respectively) is shown. The HPV E7(21–29) peptide containing the
LXCXEmotif (Protein Data Bank code 1GUX; red) binds to a conserved surface
cleft located in the B subdomain,whereas the E2F-TD(407–426) peptide (Pro-
teinData Bank code 1N4M; green) binds to a conserved groove formedby the
A/B interface. The three tryptophan residues in RbAB are depicted (cyan
spheres) and are located in the hydrophobic core of the A subdomain (Trp-
516), in the A/B interface (Trp-563), and in the B subdomain (Trp-681). The
fraction of accessible surface area for these residues is 0.41 (Trp-516), 0.00
(Trp-563), and 0.01 (Trp-681).
Marginal Stability of the RbABDomain
18924 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 26•JUNE 28, 2013
 by Luis Ielpi on July 1, 2013http://www.jbc.org/Downloaded from 
In this work, we present the first report on the conforma-
tional stability and folding of the RbAB pocket domain, which
presents the main interaction sites with both cellular and viral
proteins and is the site of most tumorigenic point mutations.
We show that RbAB is marginally stable and presents multiple
conformations in solution including a folding intermediate in
which the LXCXE and E2F binding sites are disrupted. Based on
our results, we discuss the possibility that, similar to other clin-
ically relevant tumor suppressors, RbABmarginal stability may
underlie its inactivation in cancer. These properties may be an
evolutionarily conserved feature of cyclin fold superfamily pro-
teins that allows the multiple interactions involved in cell sig-
naling regulatory networks.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification and Peptide Synthesis
The human RbAB domain (residues 372–787) was expressed
and purified as described previously (47). The sample was
stored in 20 mM sodium phosphate, pH 7.0, 200 mM NaCl, and
2 mM DTT. Protein purity was95% as judged by SDS-PAGE
and MALDI-TOF mass spectrometry (Bruker Daltonics, Bil-
lerica,MA). The purified domainwas homogeneous andmono-
meric as indicated by static light scattering measurements (see
below), which yielded amolecular mass of 49 kDa. Protein con-
centration was determined by the Bradford method or by UV
spectroscopy using a molar extinction coefficient for RbAB
(280 nm 43,350 M1cm1) (48). The E7 peptides used in this
work have been described previously in detail (47). Peptides
were synthesized by Fmoc (N-(9-fluorenyl)methoxycarbonyl)
chemistry (W. M. Keck Facility, Yale University, New Haven,
CT). Peptideswere quantified byUVabsorbance at 276nm, and
peptides lacking tyrosine residues were quantified by absor-
bance at 220 nm.
Chemicals and Solutions
Unless stated otherwise, measurements were performed in
20mM sodium phosphate buffer at pH 7.0, 200mMNaCl, and 2
mM DTT at 20  0.1 °C using analytical grade chemical
reagents (Sigma-Aldrich or ICN).
Light ScatteringMeasurements
Static Light Scattering—The average molecular weight of
RbAB was determined on a Precision Detectors PD2010 light
scattering instrument connected in tandem to a high perfor-
mance liquid chromatography system and an LKB 2142 differ-
ential refractometer. We used a Superdex 200 HR 10/30 (24-
ml) gel filtration column (GEHealthcare) and injected 150l of
a 1 mg/ml (20 M) protein sample at a 0.5 ml/min flow rate.
The buffer was 20 mM sodium phosphate, pH 7.0, 0.1 M NaCl,
and 1 mM DTT. The 90° light scattering and refractive index
signals of the eluting material were recorded on a PC computer
and analyzed with the Discovery32 software supplied by Preci-
sion Detectors.
Dynamic Light Scattering (DLS)—Measurements were per-
formed on a ZetasizerNano SDLS device fromMalvern Instru-
ments. 10 M RbAB samples in different solvent conditions
were prepared and filtered prior to measurement with Ultra-
free-MCmicrocentrifuge filters (0.22m;Millipore). The aver-
age hydrodynamic radius and standard deviation were calcu-
lated by Gaussian fitting of the particle size distribution curves
using the instrument software. The average number of mono-
mers (n) in the oligomeric RbAB samples was calculated from
the average volume (v) and hydrodynamic radius of the ensem-
ble (RS) where theRmon is the radius of a native RbABmonomer
(Rmon  3.85 nm) and 1.2 is the average relationship between
the hydrodynamic radii of partially folded and native mono-
mers (49).
n 
RS
3
1.2  Rmon
3 (Eq. 1)
Circular Dichroism Spectroscopy
Measurements were conducted on a Jasco J-810 spectropo-
larimeter using a Peltier temperature-controlled cell. Far-UV
circular dichroism (CD) spectra were recorded between 200
and 260 nm at standard sensitivity at a rate of 100 nm/min with
4-s response time, 0.2-nm data pitch, and 1-nm bandwidth.
Spectrawere an average of at least five scans after subtraction of
buffer spectra. Near-UV CDmeasurements were performed in
the 250–360 nm range using the same equipment parameters
at high sensitivity and 50–90 M RbAB concentration. Raw
data were converted to molar ellipticity using the relationship
	MRW 
deg
c	 #bonds
 L 10,000
(Eq. 2)
where deg is the raw signal in millidegrees, [c] is protein concen-
tration in molar units, #bonds is the number of peptide bonds
(number of amino acids 1), and L is the path length in cm.
Fluorescence Spectroscopy
Fluorescence emission spectra were recorded on a Jasco
FP-6500 spectrofluorometer with an excitation wavelength of
295 nm, and the emission spectrum was recorded from 310 to
400 nm using excitation and emission bandwidths of 5 nm,
respectively, and a scan speed of 100 nm/min. Fluorescence
emission data were analyzed by first subtracting the buffer
background at the appropriate guanidinium chloride (GdmCl)
concentration, and the center of spectral mass of the emission
spectrum was quantified as
CSMcm1 iFiFi (Eq. 3)
where Fi is the fluorescence emission at wave number i and the
summation is carried out over the range of measured values of
F. Spectra of RbAB at concentrations above 1Mwere recorded
in a 4-mm-path length quartz cell, and those below 1 M were
recorded in a 10-mm-path length cell. All data shown were
obtained from averaging three to five spectra.
1-Anilinonaphtalene 8-Sulfonate (ANS) and Thioflavin T (ThT)
Binding
Binding to ANS and ThT was measured by fluorescence
spectroscopy. For ANS binding experiments, 2–4 M protein
was added to 100 mM citrate-phosphate buffer solution equili-
brated at the indicated pH value (2.0 or 7.0) containing 60 M
Marginal Stability of the RbABDomain
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ANS. Fluorescence spectra were recorded with excitation at
370 nm using a 5-nm excitation and emission bandwidth,
respectively, and ANS binding was detected by an increase in
fluorescence at 470 nm. For ThT binding experiments, 2–4M
protein was added to 100mM citrate-phosphate buffer solution
equilibrated at the indicated pH value (2.0 or 7.0) containing 20
MThT. Fluorescence spectra were recordedwith excitation at
435 nm using a 5-nm excitation and emission bandwidth,
respectively, and ThT binding was detected by an increase in
probe fluorescence at 480 nm.
GdmCl and Urea EquilibriumUnfolding
Experiments were performed by equilibrating the protein in
tubes containing 20 mM sodium phosphate buffer, pH 7.0, 200
mM NaCl, and 2 mM DTT at 20 °C and increasing GdmCl or
urea concentrations. Samples were incubated for 30 min prior
to measurement of CD and tryptophan emission spectra
because unfolding kinetics indicated that the equilibrium was
reached within 200 s.
RbAB Denaturation in the Presence of E7 Peptides—Unfold-
ing experiments in the presence of peptide ligands were per-
formed in themanner described above except that a preformed
RbABpeptide complex was added to the tubes containing
denaturant instead of RbAB alone. The final concentrations in
the experiments were 1 M RbAB and 10 M peptide.
Data Analysis and Fitting—GdmCl denaturation curves
were fit to a three-state model (see Scheme 1). Spectroscopic
signals were fit to a linear model,
y  N in  Nm [Den] 
 fN Iin Im  [Den]

 fI fN Uin Um [Den] 
 fU (Eq. 4)
where y is the measured signal;Nin, Iin, andUin are the spectro-
scopic signals of the native, intermediate, and unfolded mono-
mers, respectively; and Nm, Im, and Um are parameters that
account for the linear variation of these signals with denaturant
concentration ([Den]). The fractions of native, intermediate,
and unfolded monomers are fN, fI, and fU and are defined as
fN 
1
1 KD1 KD1 KD2
(Eq. 5)
f I
KD1
1 KD1 KD1 KD2
(Eq. 6)
fU 
KD1 KD2
1 KD1 KD1 KD2
(Eq. 7)
KD1  e
G1H2O m1 [Den] (Eq. 8)
KD2  e
G2H2O m2 [Den] (Eq. 9)
where R is the gas constant, T is the temperature, KD1 and
G1H2O and KD2 and G2H2O are the equilibrium dissociation
constants and free energies of unfolding of the first and second
transitions, respectively, and m1 and m2 are m-values for each
transition. Global data fitting of experiments at 1 and 5 M
RbAB concentrationswas performed to obtain thermodynamic
parameters for each transition. Data sets for CD and center of
spectral mass (CSM) signals were fit separately. Urea denatur-
ation curves were fit to a two-state model considering native
(“N”) and partially folded intermediate (“I”) monomers. The
spectroscopic signals were fit to the equation
y NinNm [Den] 
 fN Iin Im [Den] 
 fI
(Eq. 10)
where y is themeasured signal,Nin and Iin are the spectroscopic
signals of the native and intermediate states, respectively, and
Nm and Im account for the linear variation of the signals with
denaturant concentration ([Den]). The fractions of native and
intermediate species (fN and fI) are defined as
fN 
1
1 KD
(Eq. 11)
f I
KD
1 KD
(Eq. 12)
KD  e
GH2O m [Den] (Eq. 13)
where R is the gas constant, T is the temperature, KD and
GH2O are the equilibrium dissociation constant and free
energy of unfolding, respectively, and m is the m-value for the
transition. Parameterswere estimated fromglobal fitting on the
CD and tryptophan center of mass signals on experiments per-
formed at 1MRbAB concentration.Data sets forCDandCSM
signals were also fit separately to obtain the spectroscopic
parameters for each state. For urea denaturation in the pres-
ence of RbAB ligands, data were fit to a model that considers
coupled binding and folding (see Scheme 2). The global free
energy of unfolding (50) is described by
GUNF,LIG
0,H2O GUNF
0,H2O RT ln1 KD,BIND
 [Lig]
(Eq. 14)
where GUNF0,H2O is the free energy of unfolding in the absence of
ligands, KD,BIND is the equilibrium dissociation constant for
binding of the native species to the ligand, and [Lig] is ligand
concentration in the reaction. Global data fitting on theCD and
CSM signals was performed on denaturation curves performed
at 1 M RbAB concentration and 10 M ligand concentration.
We restricted the fits using the GUNF0,H2O and mUNF values
obtained from fits of denaturation curves in the absence of
ligand, which allowed us to estimate theKD,BIND values for each
ligand. Fittings were carried out using Profit software (Quan-
tumsoft, Zurich, Switzerland).
Thermal Scans
Thermal denaturation scanswere performed on a Jasco J-810
spectropolarimeter using a Peltier temperature-controlled cell.
Ellipticity at 220 nm was recorded as the temperature was
increased at a constant speed from 20 to 80 °Cwith 2-nm band-
width, 4-s response time, and 0.2 °C data pitch. The scan rate
was varied from 0.5 to 5 °C/min.
Thermal Scans of RbABPeptide Complexes—Experiments
like those described above were performed on preformed com-
plexes of 2 M RbAB with 20 M peptide ligands. None of the
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peptide ligands presented ellipticity changes in the temperature
range assayed, ensuring that all changes in the CD signal corre-
sponded to the RbAB domain.
Data Analysis—Thermal scans were fit to an irreversible
denaturationmodel (see Scheme 3) (51, 52) that involves a first-
order kinetic conversion from the native state N to a “final”
state (F in this model). This model can describe denaturation
reactions including on- or off-pathway intermediates provided
that the overall process is irreversible. The rate constant k is
assumed to changewith temperature following the relationship
k  e 
Ea
RT 1T  1T* (Eq. 15)
where Ea is the activation energy, R is the gas constant, T is
temperature, andT* is the temperaturewhere k 1min1. The
change in molar ellipticity with temperature was fit according
to the function
	MRW,220 nm  N0 Nm x e
e
Ea  x Tm
RTm2  U0 Um x
 1 ee
Ea  x Tm
RTm2  (Eq. 16)
where []MRW220 nm is the measured signal, the variable x is
temperature in K, N0 and U0 are the signals of the native and
denatured states at 0 K, respectively, and Nm and N0 are con-
stants that allow for a linear increase or decrease of the base-
line signals as a function of temperature for the native and
denatured states. Ea(app) andTm(app) are the apparent activation
energy and melting temperature, respectively. R is the gas con-
stant (1.995103 kcal/molK).
Isothermal Denaturation Kinetics
The denaturation reaction was followed by recording elastic
scattering at 360 nm in aUV spectrophotometer (AmincoBow-
man) and the far-UV CD signal at 220 nm following transfer of
the RbAB domain from a concentrated stock solution held at
4 °C to a cuvette containing 20 mM sodium phosphate buffer,
pH 7.0, 200 mM NaCl, and 2 mM DTT pre-equilibrated at dif-
ferent temperatures without sample stirring. The concentra-
tion dependence of the reaction was measured at 45 °C in a
0.2-cm-path length cell by varying RbAB concentration from
0.1 to 4 M. Both the elastic scattering and CD signals were
followed until the reactions reached saturation. The tempera-
ture dependence of the reaction was measured at 0.5 M con-
centration in a 0.5-cm-path length cell.
Isothermal Denaturation Kinetics in the Presence of Peptide
Ligands—Experiments were performed as detailed above
except that a preformed RbABpeptide complex was added
to the cuvette at 2 M RbAB and 20 M peptide final
concentration.
Data Analysis—Model-free T50 values were calculated by
determining the initial and saturation values of the signal and
by calculating the time at which the signal change was 50% of
the total change observed. TheVE (elongation speed) value was
experimentally determined as the slope of the traces centered at
30% signal saturation. For both parameters, the standard devi-
ations were less than 1%. We used a kinetically limited model
developed by Zlotnick et al. (53) to analyze the mechanism of
nucleated oligomerization. The size of the nucleus can be esti-
mated from the slope of a log-log plot of [RbABagg] as a function
of [RbABmon],
log[RbABagg] log k n log[RbABmon] (Eq. 17)
where k is a proportionality constant and n is the size of the
oligomerization nucleus. We estimated [RbABagg] and
[RbABmon] at different timepoints in the oligomerization kinetics
using the normalized elastic scattering signal as a proxy for
aggregate concentration.We defined [RbABagg] [RbABtot]

Scattering signal and [RbABmon] [RbABtot]
 (1 Scattering
signal).
The order of the polymerization reaction was calculated
from the log(VE) versus log(Ctot) curve,
logVE C l logCtot (Eq. 18)
whereCtot is the total RbAB concentration,C is a constant, and
l is the elongation order.
RESULTS
Characterization of the RbAB Native State—We began by
exploring the solutionconditionsunderwhich theRbABmono-
mer was stable by assessing its solubility after a 1-h incubation
in buffer equilibrated at different pH values. As shown in Fig.
2A, the RbAB domain was highly soluble between pH 6.0 and
8.0, but aggregation occurred at pH values approaching its the-
oretical pI (8.9). Surprisingly, RbAB aggregated between pH 3.0
and 5.0 possibly due to titration of yet unidentified acidic resi-
dues. RbAB was soluble both at low and neutral pH, which
prompted us to compare the conformation of the soluble spe-
cies obtained at pH 2.0 and 7.0. The far-UV CD spectrum of
RbAB at pH 7.0 presented the characteristic minima at 208 and
222 nm, indicating a high content of 	-helical secondary struc-
ture (Fig. 2B), as expected from the known crystal structures
(Fig. 1). At pH 2.0, RbAB retained a high content of secondary
structure, indicating that it was still largely folded, but its
far-UV CD spectrum suggested an added component of

-sheet structure (Fig. 2B). To assess 
-sheet content, we mea-
sured ThT binding by RbAB. ThT binding was increased at pH
2.0 compared with pH 7.0, further suggesting the formation of
elements of repetitive 
-sheet structure at low pH (Fig. 2C).
RbAB tertiary structurewas evaluated by assessing the environ-
ment of tryptophan residues by near-UVCDand by tryptophan
fluorescence. TheRbABdomain presents three tryptophan res-
idues that have low solvent accessibility and are located in the
hydrophobic cores of the A subdomain, the A/B interface, and
the hydrophobic core of the B subdomain (Fig. 1). At pH7.0, the
near-UV CD spectrum presented a negative band centered at
280nm (Fig. 2D), indicating that tryptophan residueswere in an
asymmetric environment. This environment was partially dis-
rupted at pH 2.0 as shown by the decrease in intensity of the CD
band at 280 nm (Fig. 2D). The tryptophan fluorescence spec-
trum at pH7.0 presented amaximumat 328 nm, indicating that
the tryptophan residues were solvent-protected as expected for
the native state (Fig. 1), whereas at pH 2.0, the shift of this
maximum to 340 nm revealed a higher exposure of these resi-
dues to solvent (Fig. 2D, inset). In addition, RbAB presented
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high ANS binding at pH 2.0 in comparison with pH 7.0 as
shown by a strong increase in ANS fluorescence emission
intensity (Fig. 2E). This indicated that at low pH there was a
higher exposure of hydrophobic regions to the solvent. The
oligomerization state at low pH was investigated by DLS (Fig.
2F). At pH 7.0, RbAB presented a homogeneous particle size
distribution with hydrodynamic radius RS  3.85  0.07 nm.
This value was slightly higher than that expected for a globular
52-kDa monomer (RS  3.1 nm), which is likely due to the
elongated shape of the molecule. At pH 2.0, RbAB presented a
broader particle size distribution with RS 23 4 nm, indica-
tive of an oligomer, which was predicted to correspond roughly
to 120 monomers (49) (see “Experimental Procedures”). This
soluble oligomer displayed high stability to thermal denatur-
ation with no changes in its CD spectrum up to 80 °C, and its
formation was an irreversible process (not shown). Therefore,
although at pH 7.0 RbAB is a monomer that presents a native
conformation and consolidated tertiary structure, at pH 2.0,
RbAB remains largely folded but forms soluble oligomers with
an increase in
-sheet structure and higher solvent accessibility
of its hydrophobic core. Because this process is irreversible, this
conformationmay become populated even in conditions where
the native state is most stable.
RbAB Domain Unfolding Involves Two Cooperative
Transitions—Although RbAB presented a native conformation
at pH7.0, small variations of ionic strength and temperature led
to changes in its stability and solubility (not shown), suggesting
that its conformational stability might be low even at neutral
pH. This issue was investigated by using GdmCl to perturb the
native state while monitoring secondary and tertiary structure
changes by circular dichroism and tryptophan fluorescence.
Concentrations up to 0.8 MGdmCl produced an increase in the
far-UV CD band at 220 nm (Fig. 3A). This was accompanied by
an increase in the intensity of the near-UV CD and tryptophan
fluorescence signals (Fig. 3, B and C) with a slight shift in the
tryptophan emission maximum (Fig. 3C), which suggested that
at low GdmCl concentrations the RbAB domain remained
folded but underwent a minor conformational rearrangement.
We identified this state as RbAB-N* to differentiate it from the
native state, RbAB-N. At 3.0 M GdmCl, RbAB presented a sig-
nificant loss of secondary structure (Fig. 3A) as well as partial
disruption of tertiary structure as shown by the decrease in the
near-UV CD band and by the red shift in the tryptophan fluo-
rescence maximum from 328 to 340 nm (Fig. 3, B and C).
Finally, at 6.0 M GdmCl, RbAB was fully unfolded (RbAB-U) as
indicated by a complete loss of the far- and near-UVCD signals
(Fig. 3, A and B) and by a shift to 355 nm of the tryptophan
emission maximum (Figs. 3C). Next, we analyzed the RbAB
denaturation process by plotting the far-UV CD and trypto-
phan CSM signals as a function of GdmCl concentration (Fig.
3D). Two distinct cooperative unfolding transitions were evi-
dent that occurred around 1.0 and 4.5 M GdmCl, respectively.
These transitions showed a concurrent loss of secondary and
tertiary structure (Fig. 3D). The partially folded species popu-
lated between the first and second transitions was identified as
RbAB-I given that its spectroscopic properties were similar to
that of molten globule-like folding intermediates (Fig. 3, A–C).
To define the best model to fit our experimental data (Fig.
3E), we assessed the oligomerization state of RbAB along the
unfolding transition byDLS. As shown in Fig. 4, theRS values of
RbAB were the same within experimental error at 0 and 0.8 M
GdmCl (Fig. 4), indicating that RbAB remained monomeric
before the first unfolding transition. The partly folded interme-
diate RbAB-I at 3.0 M GdmCl presented a particle size distribu-
FIGURE 2.Native conformation of the RbAB domain. A, fraction of soluble RbAB protein remaining after a 1-h incubation at pH values ranging from pH 2.0
to pH 9.5. The fraction of protein remaining in solution was quantified by UV spectroscopy with the pH ranges where aggregation occurred marked as gray
shaded areas. RbAB concentration was 1 M. B, far-UV CD spectrum of the RbAB domain at pH 7.0 (full line) and 2.0 (broken line). C, ThT fluorescence emission
spectrum in 100mMcitrate-Tris buffer in thepresence of RbAB at pH7.0 (full line) and 2.0 (broken line). The emission spectrumof ThT alonewas subtracted from
each trace.D, near-UV CD spectrum of the RbAB domain at pH 7.0 (full line) and 2.0 (broken line). Inset, RbAB tryptophan emission spectrum at pH 7.0 (full line)
and 2.0 (broken line). E, ANS fluorescence emission spectrum in 100mM citrate-Tris buffer in the presence of RbAB at pH 7.0 (full line) and 2.0 (broken line). The
emission spectrumofANS alonewas subtracted fromeach trace. F, particle size distributionof a 10MRbAB sample at pH7.0 (dark gray bars) and 2.0 (light gray
bars) measured by dynamic light scattering. The average particle size populationswere RS 3.85 0.07 nm (pH 7.0) and RS 23 4 nm (pH 2.0). AU, arbitrary
units; deg, degrees. Error bars represent standard deviations.
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tion (RS 11.0 1.5 nm) that was larger andmore asymmetric
than that of RbAB-N. The relationship RS(I)/RS(N) was 2.9,
which is significantly larger than the reference value for mono-
meric intermediates (54) (1.1–1.2), indicating that under these
conditions the intermediate formed oligomers of an estimated
average size of 14 units (49) (see “Experimental Procedures”).
Unfolded RbAB at 6.0 M GdmCl (RbAB-U) presented a mono-
disperse particle size distribution with RS  8.8  0.9 nm,
which is in excellent agreement with the reference value for a
denatured monomer of the same size (RS  8.9 nm (49)). The
relationship RS(U)/RS(N)  2.3 also agreed with the value
expected for denatured monomers (54) (1.3–2.0), confirming
that RbAB-U was monomeric. We next explored whether the
denaturation transitions showed a dependence on protein con-
centration as would be expected for an oligomeric intermedi-
ate. However, we did not find significant differences in the tran-
sition midpoints measured at 1 and 5 M RbAB concentrations
for either the CD or CSM signals. This could be due to the fact
that the partly folded oligomer observed at the higher concen-
trations of theDLS experimentswas not significantly populated
at the lower concentrations of the equilibrium denaturation
experiments. The data could be fit to a three-state denaturation
model that considered the population of N, I, and unfolded (U)
monomers (Fig. 3D and Scheme 1).
The CD and CSM signals were fitted separately, performing
global fits for the experiments at 1 and 5 M RbAB concentra-
tions (Fig. 3D). From these fittings, we obtained the transition
midpoints (C50 value), free energies of unfolding, andm-values
for each transition, which are shown in Table 1. For both the
N-I and the I-U transitions, the C50 values estimated from fit-
ting of the CD and CSM signals were in excellent agreement,
confirming that these transitions were characterized by a con-
current loss of secondary and tertiary structure (Table 1). The
FIGURE 3.GdmCl equilibrium unfolding of the RbAB domain. Far-UV CD spectra (A), near-UV CD spectra (B), and intrinsic tryptophan fluorescence spectra
(C) of 1MRbABat0MGdmCl (full line), 0.8MGdmCl (dashed line), 3MGdmCl (dashedanddotted line), and6MGdmCl (dotted line) are shown.D, RbABequilibrium
unfolding transition followedbymonitoringmolar ellipticity at 220nm(CD;opencircles) and tryptophan fluorescenceCSM(black circles). Protein concentration
was 1 M. Fits for each signal obtained from Equation 4 are plotted as full lines. E, fraction of N, I, and U species as a function of GdmCl concentration plotted
using Equations 5–9 and the parameters obtained from fitting of the denaturation curves (Table 1). The species populated at different GdmCl concentrations
are indicated above the graph. AU, arbitrary units; deg, degrees.
FIGURE 4. RbAB particle size distribution at different GdmCl concentra-
tions.Dynamic light scatteringmeasurements of a 10MRbAB solution in 20
mM phosphate buffer, pH 7.0, 200 mM NaCl, and 2 mM DTT with different
GdmCl concentrations. The GdmCl concentration and average Stokes radius
(RS) for each condition is indicated inside each panel. Error bars represent
standard deviations.
SCHEME 1. Three-state RbAB denaturationmodel.
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free energy of unfolding estimated from fitting of the CD and
CSM signals had an average value of GN-IH2O  5.0  1.5 kcal/
mol for the N-I transition and an average value of GI-UH2O 
32.0  6.6 kcal/mol for the I-U transition. The GH2O values
obtained by fitting of the CD and CSM signals agreed within
experimental error for both transitions (Table 1), lending fur-
ther support to the three-state model used. The average total
free energy of unfoldingwasGN-UH2O 36.5 6.8 kcal/mol. The
intermediate RbAB-I was the most stable species in solution,
being fully populated in the 1.5–4.0 M GdmCl range (Fig. 3E),
and the spectroscopic parameters estimated from the fit for
RbAB-I confirmed that this species presented partial loss of
secondary and tertiary structure (Table 1).
The m-values for the first and second transitions agreed
within experimental error for both spectroscopic probes (Table
1). We obtained average m-values of 4.8  1.3 kcal/molM for
the N-I transition and 6.9  1.5 kcal/molM for the I-U transi-
tion. These values corresponded to changes in accessible sur-
face area of 17,900 Å2 for the N-I transition and 27,500 Å2 for
the I-U transition (55). The N-I transition had anm-value cor-
responding to an average estimated number of 200 residues
(55), which corresponded well with the size of the B subdomain
and the flexible linker (180 residues), whereas the I-U transition
had anm-value corresponding to an average estimated number
of 300 residues (55), which agreed well with the size of the A
subdomain (240 residues). The sum derived from them-values
(500 residues) correspondswell with the size of the entire RbAB
domain construct (455 residues). Both the m-values and the
fact that both the N-I and the I-U transitions were highly
cooperative also suggested that each transition corre-
sponded to the unfolding of a region of the RbAB domain
with cooperatively folded structure, suggesting that the
intermediate corresponded to a species in which one sub-
domain remained mainly folded, whereas the other sub-
domain was unfolded. The number of residues derived from
the m-values suggested that the first transition corre-
sponded to unfolding of the B subdomain.
Dissection of the RbAB Unfolding Transitions by Ligand
Stabilization—To address the effect of ligands on RbAB
domain stability, we performed experiments where we added
RbAB-specific peptide ligands to the unfolding mixture. We
used two peptides derived from viral and cellular partners that
target the main binding surfaces in RbAB (Fig. 1). The first was
the E7(16–31) peptide derived from the human papillomavirus
type 16 E7 protein, which binds to the LXCXE cleft in the B
subdomain (18), and the second was the E2F-TD peptide
derived from the E2F2 transcription factor, which binds to
the A/B interface (26) (see Table 3 and Fig. 1). Using GdmCl,
we obtained very small shifts in the transition midpoints for
both peptides (not shown) likely because the ionic nature of
this chaotrope weakened the RbAB-ligand interactions (56).
Therefore, we performed these experiments using urea as
denaturant.
As opposed to the two transitions observed with GdmCl,
urea denaturation of theRbABdomain presented a single coop-
erative transition that presented concurrent changes of the CD
and CSM signals (Fig. 5A). The far-UV CD signal increased at
low denaturant concentrations as observed with GdmCl, indi-
cating that the conformational rearrangement leading to
RbAB-N* was also present in urea and ruling out that this effect
was due to ionic strength. The state populated after the transi-
tion and up to 9.0 M urea was not completely unfolded as indi-
cated by a high content of secondary structure and by a CSM
signal corresponding to partial exposure of the tryptophan res-
idues (Fig. 5,A and B). The CD spectrum of RbAB in 4.0 M urea
after the unfolding transition was very similar to that of the
RbAB intermediate populated in 3.0 M GdmCl (Fig. 5B). The
species in 4.0 M urea was clearly not unfolded as shown by
TABLE 1
Thermodynamic parameters for RbAB equilibrium unfolding
# Global fitting for each spectroscopic signal was performed on unfolding curves measured at 1 and 5 M RbAB concentration.
* Global fitting for both spectroscopic signals was performed on unfolding curves measured at 1 M RbAB concentration by normalizing the measured signals prior to fitting.
Marginal Stability of the RbABDomain
18930 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 26•JUNE 28, 2013
 by Luis Ielpi on July 1, 2013http://www.jbc.org/Downloaded from 
the difference between its CD spectrum and that of unfolded
RbAB in 6.0 MGdmCl (Fig. 5B). The data could be globally fit to
a two-statemodel (Fig. 5,A andC), yielding aC50 value of 3.1
0.7 M, an m-value of 1.8 0.3 kcal/molM, and a free energy of
unfolding of 5.5 0.8 kcal/mol, which is in excellent agreement
with the GH2O value for the N-I transition from GdmCl
unfolding (Table 1). The spectroscopic parameters of the final
state fromurea experimentswere undistinguishable from those
of the GdmCl intermediate, and the difference in m-values for
the N-I transition from GdmCl and the urea experiments (2.7-
fold) was close to that expected considering the difference in
denaturing power of both agents (55) (Table 1). This difference
also likely explains why the second unfolding transition is not
observed in urea because it would be expected to occur at C50
values of 10.4 M or higher (55), which are beyond the solubility
of urea. In addition, the partially unfolded intermediate may be
stabilized by ionic interactions that are disrupted byGdmCl but
not by urea. Together, these results strongly suggested that the
single transition observed in urea corresponded to theN-I tran-
sition from GdmCl experiments.
Next, we probed the effect of the E7(16–31) and E2F-TD
peptides on the N-I transition. Both the E2F2-TD and the
E7(16–31) peptides produced shifts in the unfolding transition
midpoint of 0.8 and 2.2 molar units, respectively (Fig. 5C). We
fitted the unfolding curves to a model that considers coupled
binding and folding equilibriums and assumes that ligands bind
only to the native state (Fig. 5C and Scheme 2).
This model allowed us to calculate the free energy of unfold-
ing and binding, which wasGUNF,LIGH2O  7.0 0.2 kcal/mol for
the RbABE2F2-TD complex and GUNF,LIGH2O  9.5  0.1 kcal/
mol for the RbABE7(16–31) complex (Table 2). The dissocia-
tion constants of the RbAB-ligand interactions calculated from
thismodelwere 1.1 0.1108 M for theRbABE7(16–31) com-
plex and 8.6  1.3107 M for the RbABE2F2-TD complex,
which are in very good agreement with the values previously
reported from anisotropy or isothermal titration calorimetry
measurements (2.1109 M for RbABE7(16–31) (56) and
1.9107 M for RbABE2F-TD (26); Table 2). This agreement
supported ourmodel, indicating that both ligands bound selec-
tively to the native state and providing evidence that the native
structures of both the LXCXE and the E2F binding clefts were
disrupted in the partially folded intermediate. These results lent
support to the picture arising from GdmCl unfolding that the
first transition corresponded to unfolding of the B subdomain
with the corresponding loss of the LXCXE binding surface. The
disruption of the E2F binding cleft in the intermediate also fits
with this scenario because unfolding of the B subdomain would
also be expected to alter the native structure of the A/B inter-
face where this binding site is located.
Low RbAB Stability Leads to Irreversible Aggregation—The
RbABdomain showed a propensity to aggregate over long incu-
bation periods at room temperature, suggesting that its thermal
stability might be low, in line with the chemical unfolding
results. To test this hypothesis, we performed thermal scanning
experiments where wemonitored secondary structure changes
as temperature was increased at a constant rate. Upon increas-
ing temperature, RbAB showed a cooperative loss of native sec-
ondary structure accompanied by visible aggregation (Fig. 6A).
The native conformation could not be recovered when temper-
ature was decreased, indicating that the process was irreversi-
ble (Fig. 6, A and B). The CD spectrum of the final state was
different from that of a disordered polypeptide and presented a
FIGURE 5.Urea denaturation and effect of peptide ligands onRbAB equi-
libriumunfolding.A, RbAB equilibriumunfolding followedbymolar elliptic-
ity at 220 nm (CD; open circles) and tryptophan fluorescence CSM (black cir-
cles). Lines are global fits to a two-state denaturationmodel (Equation 10 and
Table 1). Protein concentrationwas 1M. B, far-UVCD spectra of 1MRbAB in
0.3 M urea (full line), 4.0 M urea (dashed line), 3 M GdmCl (dotted line), and 6 M
GdmCl (dashed and dotted line). C, fraction of native protein as a function of
urea concentration for the isolated RbABdomain (CD, open circles; CSM, black
circles) and for complexes of 1M RbABwith 10M E2FTD (CD, open triangles;
CSM, black triangles) and 1 M RbAB with 10 M E7(16–31) (CD, open dia-
monds; CSM, black diamonds). Lines are global fits of the CD and CSM signals
to Equation 14. Parameters from global fitting are reported in Tables 1 and 2.
The species populated at different urea concentrations are depicted above
the graphs. deg, degrees.
SCHEME 2. Coupled binding and unfoldingmodel.
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single minimum at 225 nm (Fig. 6B), which indicated that ther-
mal denaturation did not involve full unfolding of the domain
and led to a misfolded RbAB species. As an approach to fit the
experimental curves, we applied a simple kinetic model often
used to describe irreversible thermal transitions (52) (Scheme 3
and “Experimental Procedures”).
From the curve shown in Fig. 6A, we obtained a Tm(app) of
52.2 0.1. °C. The Tm(app) value was dependent on scan speed
(not shown). This behavior is characteristic of irreversible ther-
mal denaturation and indicates that the reaction is kinetically
limited withTm(app) being higher than the truemelting temper-
ature (57). At 0.5 °C/min, Tm(app) decreased to 42.7  0.1 °C,
indicating that RbAB thermal stability was low and suggesting
that denaturation could occur spontaneously at physiological
temperature.
To characterize the mechanism of RbAB thermal denatur-
ation,we followed the time course of this process bymonitoring
the far-UVCD and elastic light scattering signals after transfer-
ring a concentrated RbAB stock kept in ice to buffer equili-
brated at different temperatures. The RbAB domain was stable
at 20 °C, whereas transfer to 37, 42, 45, and 50 °C led to protein
aggregation. We chose to characterize the thermal denatur-
ation process at 45 °C (Fig. 7). After transfer of 0.5 M RbAB to
45 °C, we observed a time-dependent decrease in the intensity
of the CD signal accompanied by a slower increase in light scat-
tering that was indicative of aggregation (Fig. 7A). The time-de-
pendent changes of the CD and scattering signals had different
dependence on protein concentration: whereas at 0.5MRbAB
the scattering signal showed a slower time course than the CD
signal, at 4MRbAB, the time course of both signals was similar
(Fig. 7, A and B). The CD kinetics was independent of protein
concentration with an average half-time of 11min, whereas the
scattering kinetics were strongly dependent on protein concen-
tration (Fig. 7C) but limited by the kinetics of the conforma-
tional change at high protein concentrations (Fig. 7B). These
results suggested that although at low concentrations the reac-
tion was limited by the polymerization process at high concen-
trations aggregation was limited by a conformational transition
of the native monomer. The time-dependent measurements
performed atmultiple protein concentrationswere next used to
dissect the oligomerization mechanism.
Both the CD and scattering signals presented a lag period
followed by a growth phase, which are characteristic of nucle-
ation-polymerization processes (53) (Fig. 7, A and B). The
extent of aggregation and the changes in the far-UV CD signal
normalized by concentration were similar for all protein con-
centrations (not shown), suggesting that a similar final statewas
reached in all reactions. Tomodel the process, we used a kinet-
ically limited model developed by Zlotnick et al. (53) in which
an oligomerization nucleus formed during the lag phase influ-
ences the kinetics of aggregation (58) according to Equation 17
(see “Experimental Procedures”). In this model, [RbABagg] and
[RbABmon] are the concentrations of RbAB aggregate and
monomer, respectively, k is a constant, and n is the size of the
oligomerization nucleus. We used the normalized scattering
signal (Fig. 7C and “Experimental Procedures”) to calculate
TABLE 2
Effect of LXCXE and E2F peptide ligands on RbAB thermodynamic stability
GUNF,LIGa C50a KD,BINDa KD,BINDb
kcal/mol M M M
RbAB E2F-TD 7.0 0.2 3.9 0.6 (8.6 1.3)
 107 (1.9 0.4)
 107 (26)c
RbAB E7(16–31) 9.5 0.1 5.3 0.9 (1.1 0.1)
 108 2.1
 109 (56)d
a Values determined in this study. Global fitting was performed on unfolding curves measured in urea at 1 M RbAB concentration and 10 M peptide using them-value and
GUNF value for the isolated RbAB domain determined in the urea unfolding of the isolated RbAB domain (Table 1). The measured CD and CSM signals were normalized
prior to fitting.
b Values obtained from literature.
c KD measured by isothermal titration calorimetry.
d KD measured by fluorescence anisotropy.
FIGURE 6. Irreversible thermal denaturation of the RbABdomain.A, RbAB
irreversible thermal denaturation scans. The far-UVCDellipticity signal at 220
nm was recorded as temperature increased from 20 to 80 °C (open circles) or
decreased from 80 to 20 °C (black circles) at a scanning speed of 3 °C/min.
Protein concentration was 2 M in a 0.1-cm-path length cell. Data were fit to
Equation 16 (see “Experimental Procedures”), obtaining a Tm(app) value of
52.2  0.1 °C. Residuals are shown below the graph. B, far-UV CD spectra of
the RbAB domain before thermal denaturation at 20 °C (full line), at the end
point of the scan at 80 °C (broken line), and after decreasing temperature to
20 °C following denaturation (dotted line).mdeg, millidegrees.
SCHEME 3. Kinetic model for irreversible denaturation.
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[RbABagg] and [RbABmon] at different time points in the
aggregation kinetics for all RbAB concentrations tested (Fig.
7D). The size of the oligomerization nucleus was obtained
from the average slope of the log-log plot of [RbABagg] as a
function of [RbABmon], obtaining a value of 2.3 0.2 (Fig. 7D).
These results indicated that the oligomerization nucleuswas an
RbAB dimer. Finally, the order of the polymerization reaction
was obtained from the slope of the log-log plot of elongation
speed as a function of monomer concentration, obtaining a
value of 1.20  0.01 (Fig. 7E and “Experimental Procedures”),
which indicated that the polymerization reaction was of first
order with respect to RbAB.
Based on our results, we propose the following minimal
model for RbAB thermal denaturation (Scheme 4). The first
step in the reaction is a unimolecular conformational transition
of the native RbABmonomerN to yield a non-nativemonomer,
“M*.” In turn, M* progresses to form the dimeric aggregation
nucleus M*2, and the reaction proceeds by the sequential addi-
tion of RbAB monomers, yielding a partially folded insoluble
aggregate AN. Although at low concentrations the reaction is
limited by the nucleation step (Scheme 4, Step B), at high con-
centrations, the conformational transition from N to M*
becomes the rate-limiting reaction (Scheme 4, Step A).
LXCXE and E2F-TD Peptide Ligands Suppress Thermal
Aggregation—Because the LXCXE and E2F-TD ligands stabi-
lized RbAB in equilibrium unfolding experiments, we asked
whether they also affected RbAB thermal stability because this
could have direct implications for the stability of this domain in
the cellularmilieu. For this purpose, wemeasured the influence
of peptide ligands on RbAB denaturation kinetics at 37 °C. The
aggregation kinetics displayed a half-time of 28 min at 5 M
[RbAB], indicating that the RbAB monomer was marginally
stable under these conditions. Next, we measured aggregation
of RbABligand complexes preassembled at 20 °C before the
temperature jump. The high affinity of both ligands (Table 2)
ensured that at the concentrations used in the experiment (5
M RbAB and 20 M peptides) all of the RbAB molecules were
in complex with peptide during the preincubation period.
Thermal denaturation following incubation with both ligands
yielded a 5-fold lower scattering value compared with the iso-
lated RbAB domain at the end point of the measurements (Fig.
8A). UV and CDmeasurements confirmed that in the presence
of either E7(16–31) or E2F-TD over 95% of RbAB remained
soluble and native at the end of the experiment (not shown),
indicating that both ligands completely suppressed RbAB
aggregation under these conditions and timewindow. Suppres-
sion of RbAB aggregationwas not observedwith a peptide from
the bovine papillomavirus E7 N-terminal domain that does not
FIGURE 7. Isothermal denaturation kinetics of the RbAB domain. A, thermal denaturation kinetics followed after adding RbAB from a concentrated stock
solutionheldat 4 °C toa0.2-cm-path length cell containingbuffer equilibratedat 45 °C. The final RbABconcentrationwas0.5M. Light gray line, CD signal;black
line, elastic scattering signal. B, thermal denaturation kinetics followed after adding RbAB from a concentrated stock solution held at 4 °C to a 0.2-cm-path
length cell containing buffer equilibrated at 45 °C. The final RbAB concentration was 4 M. Light gray line, CD signal; black line, elastic scattering signal. C,
normalized light scattering signal as a function of time for RbAB concentrations ranging from 0.2 to 4M (right to left). The dashed lines indicate the area of the
curves used for the nucleus size analysis. Each of the five data sets in Dwas obtained from time points within the dashed region. D, log-log plot of aggregate
concentration as a function of freemonomer concentration calculated according to Equation 17. Each data set represents values calculated for all total protein
concentrations at a fixed time in thedenaturation kinetics: 5 (filled circles), 10 (open circles), 15 (filled triangles), 20 (open triangles), and25min (filled squares). The
size of the nucleus (2.3  0.2) was calculated as an average of the slopes obtained for each data set. All linear fits had correlation values of r  0.89. E,
dependence of the speed of elongation (VE) on total RbAB concentration. Data points were fit to Equation 18, and the order of the reactionwas obtained from
the slope, which was 1.20 0.01 (see “Experimental Procedures”). deg, degrees.
SCHEME 4.Minimal model for RbAB thermal denaturation.
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contain the LXCXE motif or with BSA (not shown), strongly
suggesting that this effect was specific to high affinity interac-
tions. The time course of changes in the CD and scattering
signals was similar at 5M [RbAB] (Fig. 8A), indicating that the
reactionwas limited by the conformational transition fromN to
M* (Scheme 4, Step A). The E7(16–31) and E2F-TD peptides
slowed down this limiting step, suggesting that both ligands
bound strongly to the native state N but weakly to M*. This
indicated that the LXCXE and E2F binding surfaces were dis-
rupted in M* similarly to what was observed for the intermedi-
ate RbAB-I from equilibrium denaturation experiments.
We further tested the effect of RbAB ligands on thermal
stability by performing thermal scanning experiments of
RbABligand complexes at 0.05 M [NaCl]. Both complexes pre-
sented a marked increase in the Tm(app) value of 10.6 °C for
RbABE7(16–31) and 9.4 °C for RbABE2F-TD (Fig. 8B and
Table 3). The stabilization persisted at 1 M [NaCl], ruling out
effects due to nonspecific ionic interactions of the acidic pep-
tides with the basic RbAB domain (not shown). To analyze
whether this effect was dependent on the affinity of the RbAB-
ligand interactions, we performed experiments using a set of
peptides containing the LXCXE motif from high risk (HPV-16
and -18) and low risk (HPV11) E7 proteins (Table 3). Because
ionic strength is known to modulate the affinity of these inter-
actions, we performed experiments at 0.05 and 0.6 M [NaCl],
covering a range of affinities from the low nanomolar to the
submicromolar range (56) (Table 3). We observed increases in
the Tm(app) values for all peptides and conditions tested that
ranged from 7.9 to 12.5 °C (Table 3). Using the previously
known affinities of each RbABligand complex (Table 3), we
analyzed the correlation between the free energy of interaction
and the Tm(app) values obtained for the different conditions. As
shown in Fig. 8C, the magnitude of thermal stabilization
showed a strong positive correlation with the free energy of
interaction (r  0.89). Taken together, these experiments
showed that RbAB is marginally stable at 37 °C. Binding of
ligands strongly stabilizes the native state against thermal
aggregation with an early event in thermal denaturation corre-
sponding to the loss of native structure of the LXCXE and
E2F-TD binding sites (Figure 1). Moreover, stabilization is
based on specific high affinity binding of the ligands to native
RbAB, and the magnitude of stabilization correlates with the
affinity of the RbAB-ligand interactions.
FIGURE 8. Irreversible thermal denaturation of the RbABdomain at 37 °C
and effect of LXCXE and E2F-TD peptide ligands on thermal stability. A,
aggregation kinetics of the isolated RbAB domain at 37 °C and 5 M concen-
tration followed by light scattering (black line) and by far-UV CD (open circles)
and aggregation kinetics of 5 M RbAB in complex with 20 M E7(16–31)
peptide (darkgray line) orwith20ME2F-TDpeptide (broken line) followedby
light scattering. B, thermal scans of the isolatedRbABdomain at 2Mconcen-
tration (filled black circles; Tm(app) 49.5 0.1 °C) and of complexes of 2 M
RbAB domain with 20 M E7(16–31) peptide (filled black triangles; Tm(app) 
60.1  0.1 °C) or with 20 M E2F-TD peptide (open black circles; Tm(app) 
58.9 0.1 °C) (Table 2). Lines are fits to Equation 16. C, correlation between
the binding free energy and the change in apparent melting temperature
for a set of peptides containing the LXCXE motif (data are from Table 3).
The line is a linear fit of the data (correlation coefficient r 0.892). mdeg,
millidegrees.
TABLE 3
Effect of LXCXE and E2F peptide ligands on RbAB thermal stability
All measurements were performed at 2 M RbAB and 20 M peptides. Buffer was 20 mM sodium phosphate, pH 7, 2 mM DTT, and 0.01% Tween 20 at the specified NaCl
concentration. Scan speed, 3 °C/min. NA, not assessed; pS, phosphoserine.
Peptide Sequencea
Tm(app) GBINDb
0.05 M NaCl 0.6 M NaCl 0.05 M NaCl 0.6 M NaCl
°C kcal/mol
E7(16–31) QPETTDLYCYEQLNDS 10.6 0.2 8.7 0.2 12.6 10.6
E7(16–40) QPETTDLYCYEQLNDSSEEEDEIDG 12.2 0.2 8.8 0.2 13.1 10.4
E7(16–40)PP QPETTDLYCYEQLNDpSpSEEEDEIDG 12.5 0.2 10.1 0.2 14.4 11.0
E7N HPV-16 MHGDTPTLHEYMLDLQPETTDLYCYEQLNDSSEEEDEIDG 12.5 0.2 NA 13.4 NA
E7N HPV-18 MHGPKATLQDIVLHLEPQNEIPVDLLCHEQLSDSEEENDEIDG 12.2 0.2 NA 12.1 NA
E7N HPV-11 MHGRLVTLKDIVLDLQPPDPVGLHCYEQLEDSSEDEVDKVDK 7.9 0.2 NA 10.2 NA
E2F2-TD DDYLWGLEAGEGISDLFD 9.4 0.2c NA NA NA
a The HPV E7 LXCXE and the E2F-TD helix motifs are underlined and in bold.
b Values were taken from Ref. 56.
c Measurements were performed at 0.2 M NaCl.
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DISCUSSION
The acknowledgment that despite extensive sequence diver-
genceTFIIB, cyclins, andRb belong to the cyclin domain super-
family revealed a strikingly conserved architecture of proteins
involved in cell cycle control and transcriptional signaling net-
works (23). TFIIB, cyclins, and Rb also share functions related
to multisite protein recognition and present topologically con-
served ligand binding sites (22). Because both the architecture
and the protein recognition functions are conserved through-
out eukaryotic evolution, the conformational properties of the
RbAB pocket domain may reveal shared features of cyclin fold
superfamily proteins. Our work reveals that the RbAB domain
is marginally stable and that mild perturbations destabilize the
native state, leading to oligomerization, population of partially
folded states, and aggregation at temperatures compatible with
living cells (Fig. 9). This suggests that the species populated in
vitro may represent conformations accessible to the RbAB
domain in vivo with equilibria being shifted by post-transla-
tional modifications, intracellular crowding, and protein and
interdomain interactions (30) (Fig. 9). Although in vivo studies
with full-length Rb will be required to address these issues,
phosphorylation was recently shown to induce RbN-RbAB
domain interactions that lead to a transition from an extended
to a globular architecture (20, 42), highlighting Rb plasticity.
We found that the native state N can be in equilibrium with
native-like states such as “N*,” which is stabilized under mild
denaturing conditions. Although both N and N* are compact
monomers with features compatible with the reported crystal-
lographic structures (Fig. 1), N* presents small rearrangements
with respect to N that include an increase in secondary struc-
ture and packing of aromatic residues with no changes in tryp-
tophan exposure (Figs. 2, 3, and 5). This plasticity of the native
state observed in vitro may correspond to a recently reported
allosteric rearrangement of the relative orientations of the A
and B subdomains that occurs upon phosphorylation of RbN
and disrupts binding to the E2F cleft (20).
In addition, several perturbations lead to the population of
partly folded and oligomeric conformations. These include the
monomeric equilibrium folding intermediate I and the thermal
denaturation intermediate M*, which are both unable to bind
LXCXE and E2F ligands (Figs. 3, 5, 7, and 8). Although I forms
limited (14-unit) soluble oligomers, “IN,” at high protein con-
centration (Fig. 4), M* also undergoes oligomerization, leading
to the formation of insoluble aggregates, “AN” (Fig. 7). Although
it is tempting to speculate that I and M* are conformationally
equivalent species, further work will be required to assess this
hypothesis. At low pH, RbAB forms large (120-unit) folded
soluble oligomers, “IB,” with properties similar to the unfolding
intermediate I and an increase in repetitive 
-sheet structure
(Fig. 2). Even when the pH tested is unlikely to occur within the
cell, the fact that IB forms by an irreversible process may lead to
an increase in the population of this conformation, particularly
in the crowded cellular environment. These features are shared
with the wild type p53 core domain, which also populates par-
tially folded states that resemble mutant phenotypes at high
pressure (59) and acquires a molten globule-like conformation
at pH 5.0 (60).
The cyclin fold is found exclusively as a duplicated tandem in
the cyclins, TFIIB, and Rb protein family members, suggesting
that both repeats evolved together following early domain
duplication (23, 61). Our work reveals differences between the
equilibrium unfolding of RbAB and that of the only other char-
acterized cyclin fold protein, Cyclin A2. Although Cyclin A2
presents a single unfolding transition (38), RbAB presents two
distinct cooperative unfolding transitions with concurrent
changes in secondary and tertiary structure and m-values that
FIGURE 9.RbAB conformational equilibria andpossible effects of ligandbinding,mutation, or phosphorylation. The diagram represents the native and
non-native species populated by the RbAB domain. The RbAB ligand-bound form is derived from Protein Data Bank codes 1GUX and 1N4M with the LXCXE
peptide in orange and the E2F-TD peptide in red. Tumorigenicmutations located in the RbAB hydrophobic core aremapped on the RbAB structure and shown
as cyan spheres. Reversible processes are represented with double arrows, and irreversible processes are represented with one-way arrowswith RbAB species
where the B domain is unfolded marked in blue. Gray boxes indicate conformations that may be stabilized by tumorigenic mutations. Temp, temperature.
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correspond well to the size of each subdomain. This difference
in unfolding behavior may be due to the different number of
helices that augment the cyclin fold in both proteins. Both the
LXCXE and the E2F-TD clefts are disrupted in the equilibrium
folding intermediate I, suggesting that the B subdomain and
part of the A/B interface are unfolded, whereas the A sub-
domain remains folded. This would indicate that the stable A
subdomain, which is able to fold independently (62), provides a
scaffold for folding of the unstable B subdomain as seen in other
large multidomain proteins (18, 63). The structural features of
the RbAB domain with a large (2013-Å2) A/B interface contin-
uous with the core of the B subdomain (18) fit well with this
scenario. Because intermediates are rarely easy to isolate at
equilibrium (64, 65), the fully populated RbAB folding interme-
diate provides an excellent opportunity for future structural
characterization.
The average free energy of unfolding per residue for small
to medium sized proteins, G0/N, is 0.075  0.037 kcal/
molresidue (66, 67). The first RbAB unfolding transition has a
G0 value of 5 kcal/mol at 20 °C and a G0/N value of 0.025
kcal/molresidue, which is below average and well below that of
stable model proteins such as barnase and ubiquitin (with
G0/N values of 0.107 and 0.114 kcal/molresidue, respectively)
(66, 67). This low thermodynamic stability is sharedwithCyclin
A2 (G0/N 0.015 kcal/molresidue) and with the marginally
stable tumor suppressors p16INKA and p53CD (withG0/N val-
ues of 0.020 and 0.028 kcal/molresidue, respectively) (32, 38,
68). RbAB is also prone to aggregation at 37 °C and undergoes
irreversible denaturation with a half-time of 28 min (Figs. 6, 7,
and 8). This low thermal stability is also shared with Cyclin A2,
p53CD, and p16INKA. The p53CD denatures spontaneously at
37 °C with a half-time of 9 min (36), and fast cycling between
folded and unfolded states leads to aggregation by competition
of the native statewith off-pathway species (69, 70). CyclinA2 is
also thermally unstable and aggregation-prone with a melting
temperature of 45 °C (38). The thermal stability of p16INKA has
not been tested, but this protein has an unusual unfolding rate
of less than 2 s at 25 °C, suggesting that its kinetic stability at
physiological temperature is low (32). Therefore, the low ther-
modynamic and thermal stabilities of RbAB are properties
shared with both cyclin fold and tumor suppressor proteins.
Although it is tempting to speculate that RbAB marginal
stability will have strong functional implications, future
work will be required to gain a better understanding of Rb
stability in vivo.
Marginal thermodynamic and thermal stabilities have strong
consequences on the phenotype of cancer-related mutations.
Several tumorigenic p53CD mutants produce critically unsta-
ble proteins that are unfolded in native conditions (37), and
dominant negative effects could be explained by the “prion-
like” behavior of p53 whereby destabilized aggregation-prone
mutant proteins induce aggregation of wild type p53 (71, 72).
Similarly, several p16INKA mutants are destabilized and yield
partially folded or aggregated states (32). Studies from Rb also
suggest that this “critical stability” may explain oncogenic phe-
notypes because low penetrant alleles R661W and C712R show
partial growth suppression ability (73), are unstable in vivo, and
require chaperone-like activity for their function (74, 75). Most
tumorigenic missense mutations are located in the hydropho-
bic core of the RbAB domain (14), suggesting that as for p53CD
these mutations may produce a decrease in stability below crit-
ical levels, leading to partial loss of function and the population
of non-native conformations (Fig. 9).
The equilibrium between RbAB native and non-native states
is strongly influenced by LXCXE and E2F-TA ligands, which
strongly stabilize the native state (Figs. 5 and 8), suggesting that
the RbAB domain may require inter- or intramolecular inter-
actions to be held in its native conformation in vivo and that
intracellular crowding may further modulate RbAB stability
and aggregation propensity (Fig. 9). The degree of stabilization
correlates with ligand binding free energy (Fig. 8), suggesting
that the interaction affinity may determine the effects of differ-
ent targets on RbAB in vivo. Cyclin A2 is also unstable in the
absence of its ligands (38), suggesting that ligand stabilization
may be a property shared by cyclin fold family members. The
stabilizing effect of the LXCXE E7 peptide on RbAB may seem
contradictory at first because full-length E7 induces protea-
somal degradation of Rb in vivo through interaction with the
Cullin-2 ubiquitin ligase complex (76). Although these differ-
ences stress the need for future studies that address the effects
of ligands on Rb turnover, our results suggest that intermolec-
ular interactions may provide an additional route to modulate
Rb levels by regulating thermodynamic stability (31), hindering
the accessibility of proteolytic sites.
In RbAB, the metastable B subdomain coevolved with a sta-
ble A subdomain required for its folding and stabilization. The
LXCXE site in RbBmediates binding to cellular targets involved
in chromatin remodeling and to viral oncoproteins that disrupt
the network (56, 77). Unfolding of the metastable B subdomain
in vivomay promote oligomerization, providing a “scaffold” for
association of multiple protein targets and leading to alternate
conformations that contribute to its role as a “hub protein.”
Nevertheless, this hypothesis should be confirmed by in vivo
stability analysis of the full-length protein. RbAB shares mar-
ginal stability, oligomerization, and ligand binding properties
with Cyclin A2 (38), suggesting that conformational plasticity
may be functionally conserved in cyclin fold family proteins
(78). Coupling of folding, binding, and oligomerization could
provide a robust mechanism to retain network topology and
regulatory properties despite the differences between cell envi-
ronments and components in the wide variety of organisms
where Rb and cyclin fold proteins evolved (5).
Studies on the thermodynamic stability of tumor suppressors
also provide a starting point for the development of therapeutic
anticancer strategies as shown for unstable p53CD mutants
that could be rescued by small peptides or by in silico screened
molecules (33). Compounds that transiently inactivate Rb
could also be used to promote the expansion of stem cell pop-
ulations (4) with the strong medical relevance involved. Our
results suggest that small ligands may have tunable effects on
Rb stability that could be exploited for therapeutics. Further
advances in these fronts will benefit from the understanding of
the conformational equilibria, folding, and ligand interactions
of the RbAB pocket domain.
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